India Moots Regional Pandemic Platform with 10 Neighbours News 22/02/2021 • Menaka Rao Share this:Click to share on Twitter (Opens in new window)Click to share on LinkedIn (Opens in new window)Click to share on Facebook (Opens in new window)Click to email this to a friend (Opens in new window)Click to print (Opens in new window) After donating over 6 million Covid vaccines to more than 13 countries, the Indian government suggested the creation of a regional pandemic platform for preparedness and medical emergencies with its 10 neighbouring countries. At a meeting with health officials, Indian Prime Minister Narendra Modi proposed creating “a special visa scheme” for doctors and nurses to enable swift travel during health emergencies,coordinated air ambulances, a regional platform for “collating, compiling and studying data about the effectiveness of Covid-19 vaccines” and a network for “promoting technology-assisted epidemiology for preventing future pandemics.” India has reported more 11 million COVID-19 cases and over 156,000 deaths. Although cases have been declining since September last year and had considerably reduced by January, there has been an increase of about 31% in the past week, mostly in the Western state of Maharashtra. “Through our openness and determination, we have managed to achieve one of the lowest fatality rates in the world,” said Modi. “This deserves to be applauded. Today, the hopes of our region and the world are focused on rapid deployment of vaccines. In this too, we must maintain the same cooperative and collaborative spirit.” Modi was referring to the Indian government’s “Vaccine Maitri” (meaning vaccine friendship) initiative, through which the Indian government has donated more than 6.27 million doses of COVID-19 vaccines to more than 13 countries, including neighbours Bangladesh, Afghanistan, Bhutan, Myanmar and countries such as Oman, Barbados and El Salvador. It also commercially exported 10.5 million doses of vaccines to 8 countries. Modi was addressing a workshop on COVID-19 management attended by health leaders, experts and officials of Afghanistan, Bangladesh, Bhutan, Maldives, Mauritius, Nepal, Pakistan, Seychelles, Sri Lanka and India. Evoking the “spirit of collaboration” among these countries, Modi said that India and these countries have a lot in common and should share their successful health policies and schemes. “We share so many common challenges – climate change, natural disasters, poverty, illiteracy, and social and gender imbalances. But we also share the power of centuries old cultural and people-to-people linkages. If we focus on all that unites us, our region can overcome not only the present pandemic, but our other challenges too,” he said. Variants May be Associated With Surge in COVID Cases In the last few days, the Maharashtra state government reported a sudden burst of cases in the Vidarbha region, closer to Central India. The genome sequencing of a few cases in Amravati district showed “unique mutations” including E484Q, which is similar to a mutation (E484K) found in South African and Brazilian variants, according to a Times of India report. Maharashtra and Kerala account for more than 74% of the cases in the country while Chhattisgarh and Madhya Pradesh are also seeing a rise. This is in contrast to the steady downward trend of the pandemic in India since last September last year. The country is reporting an average of 12,000 cases a day, as compared to more 90,000 cases in a day in September. Experts have attributed the overall fall in COVID-19 positive cases over the past few months to herd immunity caused by widespread infection, especially in cities such as Mumbai, Pune, and Delhi which saw the largest outbreaks in the country. A recent round of sero-surveillance in Delhi between January 15 to January 23 among 28,000 people found that 56% of those surveyed had antibodies against COVID-19. “Those infected with Covid will only protect themselves but also protect others. Half the population will not transmit to others. Besides, the susceptible population is reduced by 50%,” explained Dr Sanjay Rai, from Delhi’s All India Institute of Medical Sciences. Citing a recently published study in the New England Journal of Medicine, Rai said that those who are infected are protected from disease for at least six months. The study which was conducted with more than 12,000 health workers in the UK, showed that presence of antibodies was associated with a substantially reduced risk of reinfection in six months. More than 9 million people have been at least given one dose of the vaccine. “India has a young population. About 50% of the population is under 25 years, and 65% of the population under 35 years. There could be a very large fraction of the population then which had asymptomatic infections and were not tested. They would also offer some protection to the population,” said Dr Shahid Jameel, a virologist with Ashoka University, Delhi. However, a nation-wide survey showed only one out of 5 people have been exposed to the virus. “The message is that a large proportion of the population remains vulnerable,” said Dr. Balram Bhargava, who heads Indian Council of Medical Research, that helmed the national-wide sero-survey. Meanwhile, there is some evidence that people who have already had COVID-19 can become reinfected with variants. Image Credits: https://dashboard.cowin.gov.in/. Share this:Click to share on Twitter (Opens in new window)Click to share on LinkedIn (Opens in new window)Click to share on Facebook (Opens in new window)Click to email this to a friend (Opens in new window)Click to print (Opens in new window) Combat the infodemic in health information and support health policy reporting from the global South. Our growing network of journalists in Africa, Asia, Geneva and New York connect the dots between regional realities and the big global debates, with evidence-based, open access news and analysis. To make a personal or organisational contribution click here on PayPal.